共 78 条
[51]
Bakris G.L., Wilson D.M., Burnett J.C., The renal, forearm, and hormonal responses to standing in the presence and absence of propranolol, Circulation, 74, pp. 1661-1065, (1986)
[52]
Epstein M., Oster J.R., Beta blockers and the kidney, Min Electrolyte Metab, 8, pp. 237-254, (1982)
[53]
Saunders E., Weir M.R., Kong B.W., Et al., A comparison of the efficacy and safety of a beta-blocker, calcium channel blocker, and converting enzyme inhibitor in hypertensive blacks, Arch Int Med, 150, pp. 1707-1713, (1990)
[54]
Anderson S., Rennke H.G., Brenner B.M., Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat, J Clin Invest, 77, pp. 1993-2000, (1986)
[55]
Harris D.C.H., Chan L., Schrier R.W., Remnant kidney hypermetabolism and progression of chronic renal failure, Am J Physiol, 23, pp. F267-F276, (1988)
[56]
Bauer J.H., Role of angiotensin converting enzyme inhibitors in essential and renal hypertension: Effects of Captopril and enalapril on renin-angiotensin-aldosterone, renal function, and hemodynamics, salt and water excretion and body fluid composition, Am J Med, 77, pp. 43-51, (1984)
[57]
Sowers J.R., Zemel M.B., Zemel P., Et al., Salt sensitivity in blacks. Salt intake and natriuretic substances, Hypertension, 12, pp. 485-490, (1988)
[58]
Levy S.B., Lilley J.J., Frigon R.P., Stone R.A., Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake, J Clin Invest, 60, pp. 129-138, (1977)
[59]
Kirschenbaum M.A., Stein J.H., The effect of inhibition of prostaglandin synthesis on urinary sodium excretion in the conscious dog, J Clin Invest, 57, pp. 517-521, (1970)
[60]
Saunders P.W., L-Arginine and nitric oxide in saltsensitive hypertension (Abst), Hypertension, 6A, (1994)